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Abstract  
 
Introduction 
The association between smoking and mental disorders has been confirmed by several studies 
using cross-sectional and retrospective designs. The present study illustrates the need for 
differentiating subthreshold psychiatric disorders in the analysis.   
 
Methods 
The analysis is based on cumulative ("lifetime") prevalences of mental disorders and smoking 
in the Zurich Study. This is a longitudinal community study with a stratified sample of 591 
participants and 6 interviews 1979-99. 
 
Results 
The percentage of "lifetime" smokers in the Zurich Study was higher both in persons with a 
"lifetime" psychiatric diagnosis (72%) and in persons with subthreshold disorders (60%) than 
in persons without any diagnosis (40%).  
 
Discussion 
The association between smoking and mental disorders turned out to be clearly stronger if 
subthreshold mental disorders were appropriately considered in the analyses. Constructing 
appropriate reference groups is as crucial for the analysis of mental disorders and their 
outcomes as constructing adequate diagnostic groups. 
 
  
Introduction 
 
It is well known that smoking is more frequent in people suffering from mental disorders 
(Hughes, Hatsukami, Mitchell, & Dahlgren, 1986) than in the general population. 
Associations have been found for nearly all diagnostic groups (Angst, Gamma, Benazzi, 
Ajdacic, & Rossler, 2007; Breslau & Klein, 1999; de Leon et al., 1995; de Leon & Diaz, 
2005; Diaz et al., 2009; Fergusson, Goodwin, & Horwood, 2003; John, Meyer, Rumpf, & 
Hapke, 2004; Lawrence, Mitrou, & Zubrick, 2009; Mykletun, Overland, Aaro, Liabo, & 
Stewart, 2008; Paperwalla, Levin, Weiner, & Saravay, 2004; Richter, Ahluwalia, Mosier, 
Nazir, & Ahluwalia, 2002; Waxmonsky et al., 2005; Weitzman & Chen, 2005), except for 
obsessive-compulsive disorders, for which results are unequivocal (Bejerot & Humble, 1999; 
Lawrence et al., 2009). Smoking prevalence rates can reach 55% for any disorder in 
population-based samples (Black, Zimmerman, & Coryell, 1999; Grant, Hasin, Chou, 
Stinson, & Dawson, 2004; Hughes et al., 1986; Lasser et al., 2000; Lawrence et al., 2009; 
Morris, Giese, Turnbull, Dickinson, & Johnson-Nagel, 2006; Poirier et al., 2002; Vanable, 
Carey, Carey, & Maisto, 2003). However, little information is available on the association 
between smoking and subthreshold forms of mental disorders. The term subthreshold disorder 
refers to syndromes that do not fulfil common diagnostic criteria specified by DSM or ICD 
manuals. Empirical research has shown that subthreshold disorders are associated with 
increased disability and many other negative consequences such as days lost from work 
(Broadhead, Blazer, George, & Tse, 1990; Magruder & Calderone, 2000). 
 
The aim of the present study was to examine smoking prevalence in association with mental 
disorders, and to include not only psychiatric disorders, but also subthreshold disorders in the 
analysis.  
  
Methods 
 
Zurich study 
Data from the Zurich study (Angst, Dobler-Mikola, & Binder, 1984; Angst et al., 2005) was 
used for the present analyses. The Zurich study is a prospective longitudinal study in 
psychiatric epidemiology spanning 20 years in the life of young adults. In 1978, a 
representative stratified random sample of 591 persons (292 men and 299 women) was 
constructed from 1/3 low-scorers and 2/3 high-scorers on the GSI (global severity index) 
score of the SCL-90-R. The sample was followed up in 1979, 1981, 1986, 1988, 1993 and 
1999 with a comprehensive semi- structured interview dealing with questions on symptoms 
and criteria of most psychiatric diagnoses. The Zurich study has played a major role in 
developing the concept of subthreshold disorders. 
 
Diagnostic definitions 
Diagnoses of mental disorders were made according to DSM-III or DSM-III-R (Angst et al., 
2005). Dysthymia and bipolar disorders were based on DSM-IV criteria and were 
determinable only for the last four interviews. Subthreshold variables were constructed either 
with respect to fewer symptoms (but similar duration/frequency), or with respect to shorter 
duration / lower frequency (but with the same number of symptoms). Concerning alcohol and 
drug use, DSM-IV criteria for dependence and abuse were used; subthreshold 
dependence/abuse was defined as “daily use”. No data was available for schizophrenia, other 
psychotic disorders, and personality disorders. 
 
Definition of smokers 
  
"Lifetime" smokers were defined as those who regularly consumed any tobacco product at the 
time of any of the interviews. If the number of cigarettes smoked exceeded one pack per day, 
smokers were labelled “lifetime heavy smokers".  
 
Prevalence calculation 
The prevalence of smoking and mental disorders is based on “lifetime” variables; in the 
Zurich study these are cumulative frequencies based on the twelve-month prevalence data 
assessed in each interview. In the statistical analysis, the sample was weighted to offset the 
sample stratification, i.e., to provide population estimates (Levy & Lemeshow, 1999).  
 
Calculation of associations between smoking and mental disorders 
The odds ratios were derived from a series of bivariate logistic regression analyses. A 
dichotomous variable representing lifetime occurrence of (heavy) smoking was the dependent 
variable, and dichotomous variables representing different diagnostic entities were the 
independent variables. The analyses were carried out with the survey procedure and the 
logistic procedure of Stata (version 9.2 for Macintosh). 
  
Results 
 
The cumulative prevalence of any “lifetime” mental disorder was 50.4%, and 75.8% if 
subthreshold disorders were included. In persons with any "lifetime" disorder, the cumulative 
prevalence of smoking was 72.3%; in persons with any subthreshold disorder this was 60.5%; 
finally, in persons with neither a disorder nor a subthreshold disorder it was 40.4%. The 
cumulative prevalence of smoking was highest among users of illicit drugs and alcohol, 
persons suffering from bipolar disorders, and from dysthymia (Figure 1). Conversely, it was 
lowest in obsessive compulsive disorders. 
 
Heavy smoking was found in 37.6% of participants who exhibited any disorder, in 20.7% of 
participants with any subthreshold disorder, and in 10.0% of the “healthy” participants. 
Switching the perspective from columns to rows in the cross-tabulation reveals that 3 out of 4 
"heavy smokers" had a lifetime threshold diagnosis. Heavy smoking was most prevalent in 
dysthymia, surpassing substance use disorders, and bipolar disorders. 
 
In our study, the odds ratio for lifetime smoking in people with any “lifetime” mental disorder 
compared with people without a disorder was 2.5 (1.5-4.3). For heavy smoking, instead of 
smoking, the odds ratio increased to 3.3 (1.6-6.6). However, the odds ratios changed markedly 
after separating out the subthreshold disorders, and thus creating a reference group of (mostly) 
healthy people. The odds ratios regarding lifetime smoking increased to 3.9 (2.1-7.3), and 
regarding heavy smoking to 5.4 (1.8-16.6) in people with mental disorders vs. the healthy 
group. In people with subthreshold disorders (vs. the healthy group), the figures were 2.3 (1.1-
4.6) and 2.3 (0.6-8.5) respectivel (see additional electronic table). 
  
Discussion 
 
It is well known from psychiatric epidemiology that tobacco use is more prevalent in people 
with mental disorders than in healthy men and women (Grant et al., 2004; Lasser et al., 2000; 
Lawrence et al., 2009). However, the analysis of longitudinal Zurich Study data 1979-1999 
showed, among other things, that the smoking rate was distinctly higher if subthreshold 
disorders were included in the analyses. 
 
Odds ratio of smoking is higher if subthreshold diagnoses are included 
After differentiating subthreshold disorders from the reference group of healthy people, the 
odds ratio of smoking clearly increased. This result is paradoxical as much as revealing. 
Obviously the rate of smoking in subthreshold disorders is more similar to the rate in 
"threshold disorders" than to that in mostly healthy people. Otherwise, it is likely that the odds 
ratios would not have changed. The implications of this finding are threefold. First, as 
subthreshold disorders are definitely associated with a higher probability of being a smoker, it 
is also necessary to enhance efforts for smoking prevention and cessation in people suffering 
from subthreshold disorders. Regarded the other way round, not only threshold but also 
subthreshold disorders are more frequent in smoking populations. As subthreshold disorders 
also go along with considerable impairment (Broadhead et al., 1990; Magruder & Calderone, 
2000), the pressure on smokers is actually higher than if only threshold disorders are 
discussed. Second, as almost all heavy smokers had a lifetime diagnosis (or subthreshold 
diagnosis), heavy smoking, being more easily detected than psychiatric illnesses, could serve 
as marker for poor mental health. As an third and methodological implication, the association 
between smoking and psychiatric disorders is commonly underestimated, as most studies rely 
on standard diagnostic criteria. Last but not least, the results raise the subtle question as to 
  
whether the current diagnostic criteria provide an accurate framework for assessing the 
outcomes of psychiatric disorders.  
 
Technical remarks 
The percentage of smokers in people suffering from any mental disorder in the longitudinal 
Zurich sample was as high as in other population based studies with highest prevalence rates 
(Lasser et al., 2000). Given any occurrence of a mental disorder between age 20 and age 40, 
the odds of smoking were more than two times higher than in persons experiencing no mental 
disorder. As the association of smoking and mental disorders is influenced by methodological 
issues - for instance by the definition and assessment of smoking as well as of disorders – a 
direct comparison between results from different studies is difficult. There are several 
theoretical considerations that underline the importance of longitudinal data for a valid 
assessment. First, cross-sectional retrospective assessment of lifetime diagnoses or symptoms 
has been criticised for underestimating lifetime prevalences because of the recall bias 
(Kruijshaar et al., 2005; Moffitt et al., 2009; Patten, 2009). Longitudinal prospective studies 
are less susceptible to this bias because they do not demand respondents to remember events 
that occurred several years earlier in their lifetime. Secondly, the association between lifetime 
diagnoses comprises more information than concurrent association because the former does 
not require contemporaneity of the disorders. These arguments suggest that longitudinal 
prospective data are partly responsible for the higher associations found by this study.  
 
Further findings: heavy smoking and mental disorders 
In people with mental disorders, the association with heavy smoking (smoking more than 20 
cigarettes per day) is particularly strong. Very few people without any "lifetime" psychiatric 
diagnosis turn out to be "lifetime" heavy smokers, and, conversely, "lifetime" heavy smokers 
typically have (had or will have) a "lifetime" diagnosis.  
  
 
It is well known from previous research (Diaz et al., 2009; Vanable et al., 2003; Weitzman & 
Chen, 2005) that alcohol- and drug use disorders as well as bipolar disorders are accompanied 
by an increased prevalence of smoking. As to for bipolar disorders, there appears to be a 
similar situation for tobacco use as for use of alcohol (Angst et al., 2006) seeing that bipolar 
disorders mainly account for the relation between alcohol use and mood disorders. In the light 
of previous research it was not surprising to find an increased prevalence of smokers in 
association with dysthymia as well (Dierker, Avenevoli, Stolar, & Merikangas, 2002), but a 
relatively low prevalence in people with OCD. Moreover, looking specifically at heavy 
smoking, the associations mostly become stronger. In dysthymia the change is particularly 
impressive.  
 
Strengths and Limitations 
A major strength of this study is the longitudinal prospective design in combination with the 
broad spectrum of diagnoses that have been assessed since the 1970s. However, high-risk 
diagnostic groups such as schizophrenia, personality disorders and ADHD, are lacking in the 
Zurich data. Thus, this study itself probably underestimates the odds of smoking in people 
with mental disorders – despite its advantages compared with previous research. Furthermore, 
more complex longitudinal analyses are required, to introduce confounding variables, as well 
as to account for comorbidity and the temporal sequence of diagnoses and smoking.  
 
To summarize, the risk of smoking in people with mental disorders has clearly been 
underestimated in previous research. Thus we strongly recommend including subthreshold 
diagnoses in studies on smoking and poor mental health. In particular, heavy smoking occurs 
mainly in people encountering a threshold or subthreshold psychiatric disorder. Since the 
cumulative prevalences of mental disorders are considerably high, i.e., 50% if only threshold 
  
disorders are considered, the consequences for public health are far-reaching. Among other 
things, it seems likely that improving early recognition, diagnosis and treatment of mental 
disorders might greatly contribute to the prevention of cancer, stroke and many other 
smoking-related disorders. If the association is regarded the other way round, heavy smoking 
can serve as marker for a high probability of mental disorders. This can be very useful in 
settings like general practice, where the recognition of psychological problems is often 
difficult, but nevertheless of outmost relevance for public mental health.  
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Figure 
 
 
 
Figure 1:  
Prevalence rates of smoking in relation to psychiatric disorders in the Zurich Study, 1979-
1999; after adjustment for sample stratification.  
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Table 1:  
Odds ratios of smoking in the Zurich-Study, 1979 – 1999, in relation to psychiatric disorders and subthreshold disorders; odds ratios 
after adjustment for sample stratification  
 
DISORDER THRESHOLD DIAGNOSES  THRESHOLD & SUBTHERSHOLD DIAGNOSES 
 smokers vs. other  heavy smokers vs. other  smokers vs. other  heavy smokers vs. other 
 
 N  OR1 lCl2 uCl3  N OR1 lCl uCl  N OR1 lCl uCl  N OR1 lCl uCl 
alcohol dep./ab5. 
other dx 
no dx 
111 – 14 
158 – 81 
127 – 100 
7.23 
1.70 
ref. 
2.8 
1.0 
18.4 
3.0 
 63 – 62 
60 – 179 
21 – 206 
5.73 
2.24 
ref. 
2.5 
1.0 
13.0 
4.9 
 111 – 14 
237 – 125 
48 – 56 
10.97 
2.44 
ref. 
4.0 
1.3 
30.0 
4.5 
 63 – 62 
74 – 288 
7 – 97 
9.53 
3.09 
ref. 
2.9 
1.0 
31.5 
9.6 
drug dep./ab. 
other dx 
no dx 
64 – 1 
205 – 94 
127 – 100 
202.87 
1.99 
ref. 
26.6 
1.2 
1550.
1 
3.4 
 35 – 30 
88 – 211 
21 – 206 
9.85 
2.50 
ref. 
3.6 
1.2 
26.9 
5.2 
 64 – 1 
284 – 138 
48 – 56 
307.62 
2.71 
ref. 
38.9 
1.5 
2433.
1 
5.9 
 35 – 30 
102 – 320 
7 – 97 
16.37 
3.44 
ref. 
4.3 
1.1 
61.8 
10.5 
unipolar depression 
other dx 
no dx 
105 – 40 
164 – 55 
127 – 100 
2.05 
2.87 
ref. 
1.0 
1.6 
4.1 
5.2 
 40 – 105 
83 – 136 
21 – 206 
1.79 
4.20 
ref. 
0.7 
2.0 
4.3 
8.8 
 190 – 77 
158 – 62 
48 – 56 
3.85 
2.71 
ref. 
2.0 
1.4 
7.5 
5.2 
 73 – 194 
64 – 156 
7 – 97 
4.36 
4.24 
ref. 
1.4 
1.3 
13.8 
13.4 
bipolar disorder 
other dx 
no dx 
34 – 10 
235 – 85 
127 – 100 
4.03 
2.41 
ref. 
1.2 
1.4 
 
13.7 
4.1 
 19 – 25 
104 – 216 
21 – 206 
7.62 
2.85 
ref. 
2.5 
1.4 
23.5 
5.8 
 59 – 12 
289 – 127 
48 – 56 
9.21 
2.86 
ref. 
2.8 
1.6 
30.1 
5.2 
 31 – 40 
106 – 310 
7 – 97 
12.12 
3.56 
ref. 
3.3 
1.2 
44.8 
10.9 
  
dysthymia 
other dx 
no dx 
35 – 7 
234 – 88 
127 – 100 
9.17 
2.42 
ref. 
3.3 
1.4 
25.4 
4.1 
 20 – 22 
103 – 219 
21 – 206 
21.72 
4.85 
ref. 
7.5 
1.4 
62.4 
5.8 
 35 – 7 
313 – 132 
48 – 56 
13.91 
3.07 
ref. 
4.7 
1.7 
41.2 
5.6 
 20 – 22 
117 – 328 
7 – 97 
36.10 
3.84 
ref. 
9.2 
1.3 
141.9 
11.6 
generalized anxiety 
other dx 
no dx 
77 – 27 
192 – 68 
127 – 100 
3.26 
2.53 
ref. 
1.4 
1.4 
7.4 
4.1 
 36 – 68 
87 – 173 
21 – 206 
3.24 
3.29 
ref. 
1.3 
1.6 
8.1 
6.9 
 141 – 51 
207 – 88 
48 – 56 
3.64 
2.99 
ref. 
1.8 
1.6 
7.5 
5.6 
 56 – 136 
81 – 214 
7 – 97 
4.40 
4.24 
ref. 
1.3 
1.4 
14.3 
13.1 
simple phobia 
other dx 
no dx 
57 – 15 
212 – 80 
127 – 100 
2.14 
2.68 
ref. 
0.9 
1.6 
5.1 
4.6 
 29 – 43 
94 – 198 
21 – 206 
4.55 
2.97 
ref. 
1.7 
1.4 
11.9 
6.2 
 132 – 44 
216 – 95 
48 – 56 
2.59 
3.69 
ref. 
1.3 
1.9 
5.2 
7.0 
 53 – 123 
84 – 227 
7 – 97 
3.01 
5.23 
ref. 
0.9 
1.7 
9.9 
16.1 
social phobia 
other dx 
no dx 
59 – 25 
210 – 70 
127 – 100 
3.24 
2.45 
ref. 
1.3 
1.4 
8.1 
4.2 
 29 – 55 
94 – 186 
21 – 206 
3.15 
3.30 
ref. 
1.2 
1.6 
8.6 
6.8 
 120 – 41 
228 – 98 
48 – 56 
4.27 
2.93 
ref. 
1.9 
1.6 
9.4 
5.4 
 49 – 112 
88 – 238 
7 – 97 
5.88 
3.84 
ref. 
1.8 
1.2 
19.6 
11.8 
agoraphobia 
other dx 
no dx 
37 – 11 
232 – 84 
127 – 100 
2.41 
2.56 
ref. 
0.7 
1.5 
8.2 
4.3 
 20 – 28 
103 – 213 
21 – 206 
5.51 
3.10 
ref. 
1.7 
1.5 
18.2 
6.3 
 98 – 28 
250 – 111 
48 – 56 
3.43 
3.13 
ref. 
1.5 
1.7 
7.8 
5.8 
 45 – 81 
92 – 269 
7 – 97 
5.08 
4.09 
ref. 
1.5 
1.3 
17.3 
12.5 
panic disorder 
other dx 
no dx 
34 – 12 
235 – 83 
127 – 100 
2.84 
2.53 
ref. 
0.8 
1.5 
10.0 
4.3 
 16 – 30 
107 – 211 
21 – 206 
6.79 
3.08 
ref. 
1.9 
1.5 
23.7 
6.3 
 94 – 27 
254 – 112 
48 – 56 
3.28 
3.18 
ref. 
1.3 
1.7 
8.0 
5.8 
 39 – 82 
98 – 268 
7 – 97 
5.05 
4.17 
ref. 
1.4 
1.4 
 
17.8 
12.7 
obsessive compulsive 
other dx 
no dx 
15 – 15 
254 – 80 
127 – 100 
0.62 
2.90 
ref. 
0.2 
1.7 
2.2 
4.9 
 7 – 23 
116 – 218 
21 – 206 
2.18 
3.37 
ref. 
0.4 
1.7 
10.8 
6.8 
 71 – 40 
277 – 99 
48 – 56 
2.70 
3.30 
ref. 
1.2 
1.8 
6.3 
6.1 
 26 – 85 
111 – 265 
7 – 97 
3.41 
4.48 
ref. 
0.9 
1.5 
12.7 
13.6 
bulimia 
other dx 
no dx 
7 – 5 
262 – 90 
127 – 100 
1.10 
2.61 
ref. 
0.1 
1.6 
8.2 
4.4 
 5 – 7 
118 – 234 
21 – 206 
8.30 
3.18 
ref. 
1.6 
1.6 
56.6 
6.4 
 48 – 18 
300 – 121 
48 – 56 
3.94 
3.13 
ref. 
1.3 
1.7 
11.5 
5.7 
 18 – 48 
119 – 302 
7 – 97 
4.28 
4.30 
ref. 
1.0 
1.4 
17.9 
13.0 
  
neurasthenia 
other dx 
no dx 
50 – 14 
219 – 81 
127 – 100 
2.43 
2.57 
ref. 
0.8 
1.5 
 
7.4 
4.4 
 21 – 43 
102 – 198 
21 – 206 
6.18 
2.96 
ref. 
2.1 
1.4 
18.3 
6.1 
 100 – 31 
248 – 108 
48 – 56 
3.85 
3.05 
ref. 
1.7 
1.7 
8.8 
5.6 
 39 – 92 
98 – 258 
7 – 97 
4.43 
4.26 
ref. 
1.3 
1.4 
15.3 
13.0 
1) Odds ratios, after adjusting for sample stratification. 
2) Lower confidence interval (95%) 
3) Upper confidence interval 
4) Diagnosis (DSM III or DSM IV) 
5) Diagnosis of substance dependence or abuse 
 
 
 
